In late-stage metastatic breast cancers, the ACTN4 levels decrease in the nucleus, as is observed in high-grade cancerous prostate samples, suggesting that ACTN4 is possibly deregulated in advanced stage cancers [25]. This evidence concerns the gene ACTN4 and cancer.